Publications

AMC PUBLICATIONS
(2009 until present)

2013

  1. Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious Proteasome/HDAC Inhibitor Combination Therapy for Primary Effusion Lymphoma. The Journal of Clinical Investigation. June 3, 2013; 123(6):2616-2628. doi: 10.1172/JCI64503. Epub May 1, 2013. PubMed link.

  2. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N Aboulafia D,  Einstein MH, Saah A, Darragh TM, Mitsuyasu R , Palefsky JM. High-grade Anal Intraepithelial Neoplasia among HIV-1-Infected Men Screening for a Multicenter Clinical Trial of a Human Papillomavirus Vaccine. HIV Clinical Trials. March-April 2013; 14(2):75-79. PubMed link.
  3. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, DaCosta M, Panther L, Aboulafia D, Palefsky JM. Safety and Efficacy of Topical Cidofovir to Treat High-grade Perianal and Vulvar Intraepithelial Neoplasia in HIV-positive Men and Women. AIDS. February 20, 2013; 27(4):545-551. PubMed link.
  4. Shiramizu B, Liang CY, Agsalda-Garcia M, Nagata I, Milne C, Zhu X, Killeen J, Berry JM, Goodman MT. Presence of High-risk Human Papillomavirus Genotype and Human Immunodeficiency Virus DNA in Anal High-grade and Low-grade Squamous Intraepithelial Lesions. AIDS Research and Human Retroviruses. January 2013; 29(1):178-181. PubMed link.
  5. Levine AM, Noy A, Lee J, Tam W, Ramos JC, Henry D, Parekh S, Reid E, Mitsuyasu R, Cooley T, Dezube B, Ratner L, Cesarman E, Tulpule A, for the AIDS Malignancy Consortium. Pegylated Liposomal Doxorubicin, Rituximab, Cyclosphophamide, Vincristine and Prednisone (DR-COP) in AIDS-Related Lymphoma:  AIDS Malignancy Consortium Study 047 [AMC-047]. Journal of Clinical Oncology. January 1, 2013; 31(1):58-64. PubMed link.

2012

  1. Krown SE, Roy D, Lee, JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP.  Rapamycin with Antiretroviral Therapy in AIDS-associated Kaposi Sarcoma: An AIDS Malignancy Consortium study. Journal of Acquired Immune Deficiency Syndromes. April 15, 2012; 59(5):447-454. Epub November 7, 2011. PubMed link.
  2. Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF.  CpG methylation as a Tool to Characterize Cell-free Kaposi's Sarcoma Herpesvirus DNA.  2011. The Journal of Infectious Diseases. April 2012; 205(7):1095-9. Epub February 22, 2012. PubMed link.
  3. Rais R, Zhao M, He P, Xu L, Deeken JF, Rudek MA.  Quantitation of Unbound Sunitinib and its Metabolite N-desethyl Sunitinib (SU12662) in Human Plasma by Equilibrium Dialysis and Liquid Chromatography-tandem Mass Spectrometry: Application to a Pharmacokinetic Study.  Biomedical Chromatography. January 18, 2012. doi: 10.1002/bmc.2697. [Epub ahead of print]. PubMed link.
  4. Mani D, Haigentz M Jr., Aboulafia DM. Lung Cancer in HIV Infection. Clinical Lung Cancer. January 2012; 13(1):6-13. doi: 10.1016/j.cllc.2011.05.005. Epub July 29, 2011. PubMed link.

2011

  1. Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled Analysis of AIDS Malignancy Consortium Trials Evaluating Rituximab plus CHOP or Infusional EPOCH Chemotherapy in HIV-associated Non-Hodgkin Lymphoma. Cancer. December 16, 2011. doi: 10.1002/cncr.26723. [Epub ahead of print]. PubMed link.
  2. Dittmer DP. Restricted Kaposi Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy. American Society for Microbiology. November 1, 2011; 2(6):e00138-11. doi: 10.1128/mBio.00138-11. PubMed link.
  3. Rudek MA, Flexner C, Ambinder RF. Use of Antineoplastic Agents in Patients with Cancer who have HIV/AIDS.  The Lancet Oncology. September 2011; 12(9):905-912. Epub May 12, 2011. PubMed link.
  4. Roy D, Sin S-H, Damania B, Dittmer DP. Tumor Suppressor Genes FHIT and WWOX are deleted in Primary Effusion Lymphoma (PEL) Cell Lines. Blood. August 18, 2011; 118(7):e32-9. Epub June 17, 2011. PubMed link.
  5. Ramos JC, Sin SH, Staudt MR, Roy D, Vahrson W, Dezube BJ, Harrington W Jr, Dittmer DP. Nuclear Factor kappa B (NFkB) Pathway Associated Biomarkers in AIDS Defining Malignancies. International Journal of Cancer. July 25, 2011. PubMed link.
  6. Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) Genetic Alterations in EBV-associated AIDS-related Lymphoma. Blood. May 5, 2011; 117(18):4852-4854. Epub March 15, 2011. PubMed link.
  7. Wagner-Johnston ND, Gellert L, Gocke CD, Lemas MV, Lee J, Martinez-Maza O, Ambinder RF.   Clonal Immunoglobulin DNA in the Plasma of Patients with AIDS-lymphoma.  Blood. May 5 2011; 117(18):4860-4862. Epub March 9, 2011. PMCID: PMC3100695. PubMed link.
  8. Cianfrocca M, Lee S, Von Roenn J, Rudek MA, Dezube BJ, Krown SE, Sparano JA.  Pilot Study Evaluating the Interaction between Paclitaxel and Protease Inhibitors in Patients with Human Immunodeficiency Virus-associated Kaposi’s Sarcoma: An Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) Trial.  Cancer Chemotherapy and Pharmacology. Epub January 5, 2011. PubMed link.
  9. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-related Kaposi Sarcoma. Journal of Acquired Immune Deficiency Syndromes. January 1, 2011; 56(1):64-68. PubMed link.

2010

  1. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Mitsuyasu RT, Palefsky JM. Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men. Journal of Infectious Diseases. October 15, 2010; 202(8):1246-1253. PubMed link.
  2. Noy, A. Controversies in the Treatment of Burkitt Lymphoma in AIDS. Current Opinion in Oncology. September 2010; 22(5):443-448. PubMed link.
  3. Nagaiah G, Stotler C, Orem J, Mwanda WO, Remick SC. Ocular Surface Squamous Neoplasia in Patients with HIV Infection in Sub-Saharan Africa. Current Opinion in Oncology. September 2010; 22(5):437-442. PubMed link.
  4. Einstein MH, Phaëton R. Issues in Cervical Cancer Incidence and Treatment in HIV. Current Opinion in Oncology. September 2010; 22(5):449-455. PubMed link.
  5. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi’s Sarcoma. Journal of Acquired Immune Deficiency Syndrome. September 2010; 56:64-68. PubMed link.
  6. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized Trial of Paclitaxel versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-associated Kaposi’s Sarcoma: Evidence for Symptom Palliation from Chemotherapy. Cancer. August 15, 2010; 116(16):3969-77. PubMed link.
  7. Lock EF, Ziemiecki R, Marron J, Dittmer DP. Efficiency clustering for low-density microarrays and its application to QPCR. BMC Bioinformatics. July 20 2010; 11:386. PubMed link.
  8. Chiao EY, Dezube BJ, Krown SE, Wachsman W, Brock MV, Giordano TP, Mitsuyasu R, Pantanowitz L. Time for oncologists to opt in for routine opt-out HIV testing? JAMA. July 21 2010; 304:334-339. PubMed link.

2009

  1. Sparano JA, Lee J, Kaplan LD, Levine A, Ramos JC, Ambinder R, Wachsman W, Aboulafia D, Noy A, Henry D, Von Roenn J, Dezube B, Remick S, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Rituximab plus Concurrent Infusional EPOCH Chemotherapy is Highly Effective in HIV-Associated, B-cell Non-Hodgkin's Lymphoma. Blood. Epub December 18, 2009. PubMed link.
  2. Lechowicz MJ, Dittmer DP, Lee JY, Krown SE, Wachsman W, Aboulafia D, Dezube B, Ratner L, Said J, Ambinder RF. Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid. Clinical Infectious Diseases, Infectious Diseases Society of America. December 15, 2009; 49(12):1946-1949. PubMed link.
  3. Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic Analysis of AIDS-related Diffuse Large B-cell Lymphoma and Clinical Implications in Patients from AIDS Malignancies Consortium Clinical Trials 010 and 034. Journal of Clinical Oncology. Epub September 14, 2009. October 20, 2009; 27(30):5039-48. PubMed link.
  4. Palefsky JM. Anal Cancer Prevention in HIV-positive Men and Women. Current Opinion in Oncology. September 2009; 21(5): 433-438. PubMed link.
  5. Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC. Dose-Modified Oral Chemotherapy in the Treatment of AIDS-related Non-Hodgkin’s Lymphoma in East Africa. Journal of Clinical Oncology, American Society of Clinical Oncology. Epub May 26, 2009. July 20, 2009;27(21):3480-8. PubMed link.
  6. O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, Dittmer DP. Tumor Suppressor microRNAs are Underrepresented in Primary Effusion Lymphoma and Kaposi Sarcoma. Blood. Epub February 27, 2009. June 4, 2009. 113(23):5938-5941. PubMed link.
  7. Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Effects of Chemotherapy in AIDS-associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood. Journal of Clinical Oncology. May 20, 2009; 27(15):2496-2502.  PubMed link.
  8. O’Hara AJ, Chugh P, Wang L, Netto EM, Luz E, Harrington WJ Jr, Dezube BJ, Damania B, Dittmer DP.  Pre-micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma.  PLoS Pathogens. Epub April 17, 2009. April 2009; 5(4):e1000389. PubMed link.
  9. Lu P, Yang C, Guasparri I, Harrington W, Wang YL, Cesarman E. Early Events of B-cell Receptor Signalling are not essential for the Proliferation and Viability of AIDS-related Lymphoma. Leukemia. Epub November 6, 2008. April 2009; 23(4):807-10. PubMed link.
  10. Gualco G, Queiroga EM, Weiss LM, Klumb CE, Harrington WJ Jr., Bacchi CE. Frequent Expression of Multiple Myeloma 1/Interferon Regulatory Factor 4 in Burkitt Lymphoma. Human Pathology. Epub January 13, 2009. April 2009; 40(4):565-571. PubMed link.
  11. Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Lairmore M, and the AIDS Malignancy Consortium. Human T-cell Leukemia Virus Reactivation with Progression of Adult T-cell Leukemia-Lymphoma. PLoS ONE. Epub February 10, 2009. 2009; 4(2):e4420. PubMed link.
  12. Pantanowitz L, Dezube BJ. Evolving Spectrum and Incidence of Non-AIDS-defining Malignancies. Current Opinion in HIV and AIDS. January 2009; 4(1):27-34. PubMed link.